FREEDOM (CLBS16)

Study Information

The FREEDOM trial is a Phase 2b clinical trial evaluating an autologous CD34+ cell therapy (CLBS16) for the treatment of coronary microvascular dysfunction (or "CMD") in the United States. For more information on this study, please visit ClinicalTrials.gov/ct2/show/NCT04614467 or www.freedom-trial.com.  

Status: Active - Enrolling